Oncology & Cancer

Study finds cancer patients do benefit from COVID-19 vaccination

Cancer patients who have compromised immune systems due to their disease or therapy remain at high risk for COVID-19 infection. It is why this population was one of the first to receive the COVID-19 vaccine. However, while ...

Oncology & Cancer

Proteogenomics identifies novel acute myeloid leukemia subtypes

In order to better treat patients diagnosed with acute myeloid leukemia (AML), the pathological processes and also existing subtypes of the disease must be better understood. With the help of proteome and genome analysis, ...

Oncology & Cancer

How the body fights back against cancer

New research from the University of East Anglia (UEA) and Quadram Institute reveals how our immune system can be triggered to attack cancer cells.

Oncology & Cancer

The therapeutic potential of opioid agonists in human leukemia

Leukemia, the blood cancer, is a group of hematopoietic malignancies. Many types of leukemia are associated with poor outcome. Unfortunately, during the past few decades, the first-line leukemia therapy has long been traditional ...

page 14 from 40